Policy / Pricing Trump signs order to hasten psychedelic medicine access PharmaphorumDonald Trump has signed an executive order directing the FDA to reduce regulatory hurdles that stand in the way of bringing psychedelics to patients.Policy / PricingNeuroscienceRead full story pharminent April 19, 2026 (Last updated: April 20, 2026) Pharmaphorum Donald Trump has signed an executive order directing the FDA to reduce regulatory hurdles that stand in the way of bringing psychedelics to patients. Policy / PricingNeuroscienceRead full story Post navigation Previous: Kailera makes history with record-breaking $625m IPONext: What actually drives speed in complex drug development programs Related Stories Policy / Pricing MFN affecting Swiss medicines access, says Interpharma pharminent August 13, 2026 Policy / Pricing Prior Authorization Metrics Provide New Insights into Insurer Practices, but Gaps Remain pharminent August 13, 2026 Policy / Pricing Trump signs order that nearly halves childhood immunisation coverage pharminent August 11, 2026
